Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
J Dairy Sci ; 104(11): 11832-11849, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34454757

ABSTRACT

Genomic selection has been commonly used for selection for over a decade. In this time, the rate of genetic gain has more than doubled in some countries, while inbreeding per year has also increased. Inbreeding can result in a loss of genetic diversity, decreased long-term response to selection, reduced animal performance and ultimately, decreased farm profitability. We quantified and compared changes in genetic gain and diversity resulting from genomic selection in Australian Holstein and Jersey cattle populations. To increase the accuracy of genomic selection, Australia has had a female genomic reference population since 2013, specifically designed to be representative of commercial populations and thus including both Holstein and Jersey cows. Herds that kept excellent health and fertility data were invited to join this population and most their animals were genotyped. In both breeds, the rate of genetic gain and inbreeding was greatest in bulls, and then the female genomic reference population, and finally the wider national herd. When comparing pre- and postgenomic selection, the rates of genetic gain for the national economic index has increased by ~160% in Holstein females and ~100% in Jersey females. This has been accompanied by doubling of the rates of inbreeding in female populations, and the rate of inbreeding has increased several fold in Holstein bulls since the widespread use of genomic selection. Where cow genotype data were available to perform a more accurate genomic analysis, greater rates of pedigree and genomic inbreeding were observed, indicating actual inbreeding levels could be underestimated in the national population due to gaps in pedigrees. Based on current rates of genetic gain, the female reference population is progressing ahead of the national herd and could be used to infer and track the future inbreeding and genetic trends of the national herds.


Subject(s)
Genome , Inbreeding , Animals , Australia , Cattle/genetics , Female , Genomics , Genotype , Male , Selection, Genetic
2.
J Dairy Sci ; 104(1): 539-549, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33131823

ABSTRACT

Methane is a greenhouse gas of high interest to the dairy industry, with 57% of Australia's dairy emissions attributed to enteric methane. Enteric methane emissions also constitute a loss of approximately 6.5% of ingested energy. Genetic selection offers a unique mitigation strategy to decrease the methane emissions of dairy cattle, while simultaneously improving their energy efficiency. Breeding objectives should focus on improving the overall sustainability of dairy cattle by reducing methane emissions without negatively affecting important economic traits. Common definitions for methane production, methane yield, and methane intensity are widely accepted, but there is not yet consensus for the most appropriate method to calculate residual methane production, as the different methods have not been compared. In this study, we examined 9 definitions of residual methane production. Records of individual cow methane, dry matter intake (DMI), and energy corrected milk (ECM) were obtained from 379 animals and measured over a 5-d period from 12 batches across 5 yr using the SF6 tracer method and an electronic feed recording system, respectively. The 9 methods of calculating residual methane involved genetic and phenotypic regression of methane production on a combination of DMI and ECM corrected for days in milk, parity, and experimental batch using phenotypes or direct genomic values. As direct genomic values (DGV) for DMI are not routinely evaluated in Australia at this time, DGV for FeedSaved, which is derived from DGV for residual feed intake and estimated breeding value for bodyweight, were used. Heritability estimates were calculated using univariate models, and correlations were estimated using bivariate models corrected for the fixed effects of year-batch, days in milk, and lactation number, and fitted using a genomic relationship matrix. Residual methane production candidate traits had low to moderate heritability (0.10 ± 0.09 to 0.21 ± 0.10), with residual methane production corrected for ECM being the highest. All definitions of residual methane were highly correlated phenotypically (>0.87) and genetically (>0.79) with one another and moderately to highly with other methane candidate traits (>0.59), with high standard errors. The results suggest that direct selection for a residual methane production trait would result in indirect, favorable improvement in all other methane traits. The high standard errors highlight the importance of expanding data sets by measuring more animals for their methane emissions and DMI, or through exploration of proxy traits and combining data via international collaboration.


Subject(s)
Cattle/metabolism , Methane/metabolism , Animals , Australia , Body Weight/genetics , Cattle/genetics , Dairying , Diet/veterinary , Female , Genome , Greenhouse Gases , Lactation , Milk , Phenotype , Pregnancy , Selective Breeding
3.
J Dairy Sci ; 103(3): 2460-2476, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31864748

ABSTRACT

Dairying in Australia is practiced in highly diverse climatic conditions and production systems, which means that re-ranking of genotypes could occur across environments that vary in temperature and humidity-that is, genotype-by-environment interactions (G × E) may exist. The objective of this study was to investigate G × E for heat tolerance with respect to milk production traits in Australian Holsteins. A total of 6.7 million test-day milk yield records for first, second, and third lactations from 491,562 cows and 6,410 sires that had progeny in different climatic environments were included in the analysis. The environmental gradient used was the temperature-humidity index (THI) calculated from climate data from 163 Australian public weather stations between 2003 and 2017. Data were analyzed using univariate reaction norm (RM) sire model, and the results were compared with multi-trait model (MT). The MT analysis treated test-day yields at 5th percentile (THI = 61; i.e., thermoneutral conditions), 50th percentile (THI = 67; i.e., moderate heat stress conditions), and 95th percentile (THI = 73; i.e., high heat stress conditions) of the trajectory of THI as correlated traits. A THI series of 61, 67, and 73, for example, is equivalent to average temperature and relative humidity of approximately 20°C and 45%, 25°C and 45%, and 31°C and 50%, respectively. We observed some degree of heterogeneity of additive (AG) and permanent environmental (PE) variance over the trajectory THI from RM analysis, with estimates decreasing at higher THI values more steeply for PE than for AG variance. The genetic correlations of the tests between the 5th and 95th percentiles of THI for milk, protein, and fat yield from RM were 0.88 ± 0.01 (standard error), 0.79 ± 0.01, and 0.86 ± 0.01, respectively, whereas the corresponding estimates from MT were 0.86 ± 0.02, 0.84 ± 0.03, and 0.87 ± 0.03. We observed lower genetic correlations between the 5th and 95th percentiles of THI for milk tests from recent years (i.e., 2009 and 2017) compared with earlier years (i.e., 2003 and 2008), which suggests that the level of G × E is increasing in the studied population and should be monitored especially in anticipation of future expected increase in daily average temperature and frequency of heat events. Overall, our results indicate presence of G × E at the upper extreme of the trajectory of THI, but the current extent of sire re-ranking may not justify providing separate genetic evaluations for different levels of heat stress. However, variations observed in the sire sensitivity to heat stress suggest that dairy herds in high heat load conditions could benefit more from using heat-tolerant or resilient sires.


Subject(s)
Cattle/physiology , Gene-Environment Interaction , Milk/metabolism , Animals , Australia , Cattle/genetics , Dairying , Female , Genotype , Heat-Shock Response , Humidity , Lactation , Models, Statistical , Phenotype , Temperature , Thermotolerance , Weather
4.
Sci Rep ; 7(1): 961, 2017 04 19.
Article in English | MEDLINE | ID: mdl-28424507

ABSTRACT

Heat stress, potentially affecting both the health of animals and the yield and composition of milk, occurs frequently in tropical, sub-tropical and temperate regions. A simulated acute heat stress experiment was conducted in controlled-climate chambers and milk samples collected before, during and after the heat challenge. Milk lipid composition, surveyed using LC-MS, showed significant changes in triacylglycerol (TAG) and polar lipid profiles. Heat stress (temperature-humidity index up to 84) was associated with a reduction in TAG groups containing short- and medium-chain fatty acids and a concomitant increase in those containing long-chain fatty acids. The abundance of five polar lipid classes including phosphatidylethanolamine, phosphatidylserine, phosphatidylcholine, lysophosphatidylcholine and glucosylceramide, was found to be significantly reduced during heat stress. Lysophosphatidylcholine, showing the greatest reduction in concentration, also displayed a differential response between heat tolerant and heat susceptible cows during heat stress. This phospholipid could be used as a heat stress biomarker for dairy cattle. Changes in TAG profile caused by heat stress are expected to modify the physical properties of milk fat, whereas the reduction of phospholipids may affect the nutritional value of milk. The results are discussed in relation to animal metabolism adaptation in the event of acute heat stress.


Subject(s)
Cattle/physiology , Heat-Shock Response , Lipid Metabolism , Milk/metabolism , Animals , Cattle/metabolism , Fatty Acids/analysis , Female , Lactation , Milk/chemistry , Phospholipids/analysis , Triglycerides/analysis
5.
J Dairy Sci ; 100(2): 1203-1222, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27939540

ABSTRACT

We compared the outcome of mating programs based on different evaluation models that included nonadditive genetic effects (dominance and heterozygosity) in addition to additive effects. The additive and dominance marker effects and the values of regression on average heterozygosity were estimated using 632,003 single nucleotide polymorphisms from 7,902 and 7,510 Holstein cows with calving interval and production (milk, fat, and protein yields) records, respectively. Expected progeny values were computed based on the estimated genetic effects and genotype probabilities of hypothetical progeny from matings between the available genotyped cows and the top 50 young genomic bulls. An index combining the traits based on their economic values was developed and used to evaluate the performance of different mating scenarios in terms of dollar profit. We observed that mating programs with nonadditive genetic effects performed better than a model with only additive effects. Mating programs with dominance and heterozygosity effects increased milk, fat, and protein yields by up to 38, 1.57, and 1.21 kg, respectively. The inclusion of dominance and heterozygosity effects decreased calving interval by up to 0.70 d compared with random mating. The average reduction in progeny inbreeding by the inclusion of nonadditive genetic effects in matings compared with random mating was between 0.25 to 1.57 and 0.64 to 1.57 percentage points for calving interval and production traits, respectively. The reduction in inbreeding was accompanied by an average of A$8.42 (Australian dollars) more profit per mating for a model with additive, dominance, and heterozygosity effects compared with random mating. Mate allocations that benefit from nonadditive genetic effects can improve progeny performance only in the generation where it is being implemented, and the gain from specific combining abilities cannot be accumulated over generations. Continuous updating of genomic predictions and mate allocation programs are required to benefit from nonadditive genetic effects in the long term.


Subject(s)
Breeding , Farms , Models, Genetic , Animals , Australia , Cattle , Female , Inbreeding , Male , Milk/metabolism
6.
Reprod Fertil Dev ; 2015 Feb 23.
Article in English | MEDLINE | ID: mdl-25701950

ABSTRACT

The tammar wallaby (Macropus eugenii), an Australian marsupial, has evolved a different lactation strategy compared with eutherian mammals, making it a valuable comparative model for lactation studies. The tammar mammary gland was investigated for changes in gene expression during key stages of the lactation cycle using microarrays. Differentially regulated genes were identified, annotated and subsequent gene ontologies, pathways and molecular networks analysed. Major milk-protein gene expression changes during lactation were in accord with changes in milk-protein secretion. However, other gene expression changes included changes in genes affecting mRNA stability, hormone and cytokine signalling and genes for transport and metabolism of amino acids and lipids. Some genes with large changes in expression have poorly known roles in lactation. For instance, SIM2 was upregulated at lactation initiation and may inhibit proliferation and involution of mammary epithelial cells, while FUT8 was upregulated in Phase 3 of lactation and may support the large increase in milk volume that occurs at this point in the lactation cycle. This pattern of regulation has not previously been reported and suggests that these genes may play a crucial regulatory role in marsupial milk production and are likely to play a related role in other mammals.

7.
J Dairy Sci ; 96(9): 6030-46, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23871375

ABSTRACT

Variation in the composition of microorganisms in the rumen (the rumen microbiome) of dairy cattle (Bos taurus) is of great interest because of possible links to methane emission levels. Feed additives are one method being investigated to reduce enteric methane production by dairy cattle. Here we report the effect of 2 methane-mitigating feed additives (grapemarc and a combination of lipids and tannin) on rumen microbiome profiles of Holstein dairy cattle. We used untargeted (shotgun) massively parallel sequencing of microbes present in rumen fluid to generate quantitative rumen microbiome profiles. We observed large effects of the feed additives on the rumen microbiome profiles using multiple approaches, including linear mixed modeling, hierarchical clustering, and metagenomic predictions. The effect on the fecal microbiome profiles was not detectable using hierarchical clustering, but was significant in the linear mixed model and when metagenomic predictions were used, suggesting a more subtle effect of the diets on the lower gastrointestinal microbiome. A differential representation analysis (analogous to differential expression in RNA sequencing) showed significant overlap in the contigs (which are genome fragments representing different microorganism species) that were differentially represented between experiments. These similarities suggest that, despite the different additives used, the 2 diets assessed in this investigation altered the microbiomes of the samples in similar ways. Contigs that were differentially represented in both experiments were tested for associations with methane production in an independent set of animals. These animals were not treated with a methane-mitigating diet, but did show substantial natural variation in methane emission levels. The contigs that were significantly differentially represented in response to both dietary additives showed a significant enrichment for associations with methane production. This suggests that these methane-mitigating diets have altered the rumen microbiome toward naturally low methane-emitting microbial profiles. The contig sequences are predominantly new and include Faecalibacterium spp. The contigs we have identified here are potential biomarkers for low-methane-emitting cattle.


Subject(s)
Diet/veterinary , High-Throughput Nucleotide Sequencing/veterinary , Methane/biosynthesis , Microbiota/genetics , Rumen/microbiology , Animals , Cattle/microbiology , Feces/microbiology , High-Throughput Nucleotide Sequencing/methods , Metagenome/genetics , Microbiota/drug effects , Rumen/drug effects
8.
J Immunol ; 163(11): 5860-70, 1999 Dec 01.
Article in English | MEDLINE | ID: mdl-10570270

ABSTRACT

Optimal T cell activation and expansion require engagement of the TCR plus costimulatory signals delivered through accessory molecules. SLAM (signaling lymphocytic activation molecule), a 70-kDa costimulatory molecule belonging to the Ig superfamily, was defined as a human cell surface molecule that mediated CD28-independent proliferation of human T cells and IFN-gamma production by human Th1 and Th2 clones. In this study, we describe the cloning of mouse SLAM and the production of mAb against it which reveal its expression on primary mouse T and B cells. Mouse SLAM is expressed on highly polarized Th1 and Th2 populations, and is maintained on Th1, but not on Th2 clones. Anti-mouse SLAM mAb augmented IFN-gamma production by Th1 cells and Th1 clones stimulated through the TCR, but did not induce IFN-gamma production by Th2 cells, nor their production of IL-4 or their proliferation. Mouse SLAM is a 75-kDa glycoprotein that upon tyrosine phosphorylation associates with the src homology 2-domain-containing protein tyrosine phosphatase SHP-2, but not SHP-1. Mouse SLAM also associates with the recently described human SLAM-associated protein. These studies may provide new insights into the regulation of Th1 responses.


Subject(s)
Carrier Proteins/metabolism , Glycoproteins/metabolism , Immunoglobulins/metabolism , Intracellular Signaling Peptides and Proteins , Lymphocyte Activation , Receptors, Antigen, T-Cell/metabolism , Th1 Cells/immunology , Th2 Cells/immunology , Amino Acid Sequence , Animals , Antibodies, Monoclonal , Antigens, CD , CD3 Complex/metabolism , Cloning, Molecular , Cytokines/biosynthesis , Gene Library , Genomic Library , Glycoproteins/genetics , Glycoproteins/immunology , Immunoglobulins/genetics , Immunoglobulins/immunology , Interferon-gamma/biosynthesis , Interleukin-18/pharmacology , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Protein Binding , Protein Tyrosine Phosphatase, Non-Receptor Type 11 , Protein Tyrosine Phosphatase, Non-Receptor Type 6 , Protein Tyrosine Phosphatases/metabolism , Receptors, Cell Surface , Sequence Homology, Amino Acid , Signal Transduction , Signaling Lymphocytic Activation Molecule Associated Protein , Signaling Lymphocytic Activation Molecule Family Member 1
9.
J Immunol ; 159(9): 4316-21, 1997 Nov 01.
Article in English | MEDLINE | ID: mdl-9379027

ABSTRACT

Allergen-specific Th2 cells accumulate at high frequencies in the skin of patients with atopic dermatitis (AD), where they contribute to the induction and maintenance of the lesions that are characteristic for the disease. Attenuation of these lesions in response to successful therapy is associated with a reduction in IL-4-producing Th2 cells and the appearance of IFN-gamma-producing Th cells. In this study, we demonstrate that engagement of the signaling lymphocytic activation molecule (SLAM) by an agonistic mAb, during allergen-specific expansion of highly polarized Th2 cell populations derived from skin biopsies of AD patients, results in the generation of stable populations of IFN-gamma-producing cells. SLAM-mediated reversal of Th cell phenotype has important biologic consequences, because supernatants of these activated, allergen-specific Th cells fail to induce IgE synthesis by purified B cells costimulated by anti-CD40 mAbs. Thus, highly polarized, allergen-specific Th2 cell populations derived from the skin of AD patients can be reversed into Th cell populations that contain IFN-gamma-producing cells and that do not support IgE synthesis. These results define a new mechanism to promote Th0/Th1 differentiation and suggest a potential role for anti-SLAM mAbs in the treatment of Th2-mediated allergic diseases.


Subject(s)
Dermatitis, Atopic/immunology , Glycoproteins/immunology , Immunoglobulins/immunology , Signal Transduction/immunology , Skin/immunology , Th2 Cells/immunology , Antigens, CD , Cell Differentiation/immunology , Cell Movement , Humans , Immunity, Cellular , Receptors, Antigen, T-Cell/immunology , Receptors, Cell Surface , Signaling Lymphocytic Activation Molecule Family Member 1 , Skin/pathology , Th2 Cells/cytology
10.
J Immunol ; 159(6): 2986-93, 1997 Sep 15.
Article in English | MEDLINE | ID: mdl-9300723

ABSTRACT

In the present study the expression and function of signaling lymphocytic activation molecule (SLAM) in lymphocytes from patients with rheumatoid arthritis (RA) were investigated. The expression levels of SLAM were significantly up-regulated on synovial fluid and synovial tissue T cells from patients with RA compared with peripheral blood T cells from the same patients or from healthy volunteers. In addition, the expression of SLAM on peripheral blood B cells from patients with RA was elevated compared with that in healthy volunteers. SLAM+ T cells in synovial fluid coexpressed CD45RO and demonstrated decreased expression of CD27, indicative of a primed phenotype. In addition, the activation state of SLAM+ T cells was enhanced, as judged by increased expression of CD25, CD28, CD69, and CD95 on these cells. Interestingly, SLAM expression on activated CD4+ and CD8+ T cells from both patients and healthy individuals could be down-regulated by IL-10, which has been previously shown to function as an anti-inflammatory molecule in rheumatoid synovium. Furthermore, anti-SLAM mAbs increased the production of IL-10, IFN-gamma, and TNF-alpha by in vitro activated synovial fluid mononuclear cells, supporting the idea that signaling through SLAM may play a role in the regulation of synovial inflammation in patients with RA. Given the fact that SLAM was recently shown to be a high affinity self ligand, our data suggest that synovial T cells may stimulate their own cytokine production through homophilic SLAM-SLAM interactions.


Subject(s)
Arthritis, Rheumatoid/immunology , Cytokines/biosynthesis , Glycoproteins/biosynthesis , Immunoglobulins/biosynthesis , Signal Transduction/immunology , Synovial Membrane/immunology , Adult , Aged , Aged, 80 and over , Antigens, CD/biosynthesis , Cytokines/immunology , Flow Cytometry , Glycoproteins/immunology , Humans , Immunoglobulins/immunology , Immunophenotyping , Lymphocyte Activation , Middle Aged , Receptors, Cell Surface , Signaling Lymphocytic Activation Molecule Family Member 1
11.
J Immunol ; 158(9): 4036-44, 1997 May 01.
Article in English | MEDLINE | ID: mdl-9126961

ABSTRACT

The expression and function of the novel signaling lymphocytic activation molecule (SLAM) are described. SLAM is present on immature thymocytes, CD45R0(high) memory T cells, T cell clones, CD56+ T cells, EBV-transformed B-cell lines and on a proportion of B cells. SLAM is rapidly induced on naive T cells, TCR gammadelta+ T cells, and B cells following activation. Engagement of SLAM by the agonistic anti-SLAM mAb A12 resulted in proliferation of T cell clones and Ag- or PHA-activated peripheral blood T cells. mAb A12-induced T cell proliferation is independent of IL-2 and sensitive to inhibition by cyclosporin A. The extent of the anti-SLAM-induced proliferation was related to the activation state of the T cells, since fully rested T cell clones failed to proliferate in response to mAb A12 stimulation, despite unchanged SLAM expression on their surface. Ligation of SLAM on activated peripheral T cells or T cell clones by mAb A12 induced IFN-gamma production in the absence of other exogenous stimuli, even in allergen-specific Th2 clones. These data indicate that stimulation via SLAM reverses the cytokine production profile of Th2 clones to a Th0 phenotype, whereas it further polarizes cytokine production by Th1 clones. Thus, SLAM is a novel receptor that mediates IL-2-independent expansion of activated T cells during immune responses, while concomitantly directing these proliferating cells to a Th0/Th1 pathway.


Subject(s)
Glycoproteins/physiology , Immunoglobulins/physiology , Receptors, Immunologic/immunology , T-Lymphocytes/immunology , Antibodies, Monoclonal/immunology , Antigens, CD , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cyclosporine/pharmacology , Flow Cytometry , Gene Expression , Humans , Interferon-gamma/biosynthesis , Interleukin-2/physiology , Lymphocyte Activation , RNA, Messenger/genetics , Receptors, Cell Surface , Signaling Lymphocytic Activation Molecule Family Member 1 , T-Lymphocytes/cytology , Th1 Cells/immunology , Up-Regulation
12.
Immunol Cell Biol ; 75(2): 202-5, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9107577

ABSTRACT

Following the initial events of T cell activation, triggered by binding of specific peptide-MHC complex to the TCR for antigen and engagement of costimulatory molecules, a number of activation molecules are expressed on the cell surface. Many of these molecules regulate T cell function, T-T cell interactions and the interaction of T cells with other cells. One such molecule is SLAM, a multifunctional 70 kDa glycoprotein member of the Ig superfamily with multiple isoforms. SLAM is rapidly induced on naive T cells and B cells following activation. Engagement of SLAM by a specific antibody (mAb A12) results in IL-2-independent T cell expansion and induction/up-regulation of IFN-gamma by activated T cells, including Th2 cells. SLAM was found to be a high-affinity self-ligand mediating molecular and cellular homophilic interactions. In this review we discuss SLAM as a receptor involved in T cell expansion and in directing immune responses to a Th0-Th1 pathway.


Subject(s)
DNA, Complementary/genetics , Glycoproteins/immunology , Immunoglobulins/immunology , Lymphocyte Activation , T-Lymphocytes/immunology , Antigens, CD , Gene Expression , Glycoproteins/genetics , Humans , Immunoglobulins/genetics , Interferon-gamma/metabolism , Interleukin-2/metabolism , Receptors, Cell Surface , Signaling Lymphocytic Activation Molecule Family Member 1 , T-Lymphocytes/metabolism , Th1 Cells/metabolism , Th2 Cells/metabolism
13.
J Exp Med ; 185(6): 993-1004, 1997 Mar 17.
Article in English | MEDLINE | ID: mdl-9091591

ABSTRACT

In this study it is shown that both membrane-bound and soluble forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B cells. Activated B cells express the membrane-bound form of SLAM (mSLAM), the soluble (s) and the cytoplasmic (c) isoforms of SLAM, and the expression levels of mSLAM on B cells are rapidly upregulated after activation in vitro. Importantly, recombinant sSLAM and L cells transfected with mSLAM efficiently enhance B cell proliferation induced by anti-mu mAbs, anti-CD40 mAbs or Staphylococcus aureus Cowan I (SAC) in the presence or absence of IL-2, IL-4, IL-10, IL-12, or IL-15. sSLAM strongly enhances proliferation of both freshly isolated B cells and B cells derived from long-term in vitro cultures, indicating that SLAM acts not only during the initial phase of B cell activation but also during the expansion of preactivated B cells. In addition, sSLAM enhances production of IgM, IgG, and IgA by B cells activated by anti-CD40 mAbs. SLAM has recently been shown to be a high affinity self-ligand, and the present data suggest that signaling through homophilic SLAM-SLAM binding during B-B and B-T cell interactions enhances the expansion and differentiation of activated B cells.


Subject(s)
B-Lymphocytes/immunology , Glycoproteins/pharmacology , Glycoproteins/physiology , Immunoglobulins/pharmacology , Immunoglobulins/physiology , Lymphocyte Activation , Animals , Antibody Formation , Antigens, CD , B-Lymphocytes/drug effects , Cell Membrane/physiology , Cells, Cultured , DNA Primers , Glycoproteins/biosynthesis , Humans , Hypoxanthine Phosphoribosyltransferase/biosynthesis , Immunoglobulins/biosynthesis , Interleukins/pharmacology , Kinetics , L Cells , Mice , Polymerase Chain Reaction , Receptors, Cell Surface , Recombinant Proteins/biosynthesis , Recombinant Proteins/pharmacology , Signal Transduction , Signaling Lymphocytic Activation Molecule Family Member 1 , Spleen/immunology , Transfection
14.
Proc Natl Acad Sci U S A ; 93(26): 15086-91, 1996 Dec 24.
Article in English | MEDLINE | ID: mdl-8986768

ABSTRACT

Escherichia coli selenophosphate synthetase (SPS, the selD gene product) catalyzes the production of monoselenophosphate, the selenium donor compound required for synthesis of selenocysteine (Sec) and seleno-tRNAs. We report the molecular cloning of human and mouse homologs of the selD gene, designated Sps2, which contains an in-frame TGA codon at a site corresponding to the enzyme's putative active site. These sequences allow the identification of selD gene homologs in the genomes of the bacterium Haemophilus influenzae and the archaeon Methanococcus jannaschii, which had been previously misinterpreted due to their in-frame TGA codon. Sps2 mRNA levels are elevated in organs previously implicated in the synthesis of selenoproteins and in active sites of blood cell development. In addition, we show that Sps2 mRNA is up-regulated upon activation of T lymphocytes and have mapped the Sps2 gene to mouse chromosome 7. Using the mouse gene isolated from the hematopoietic cell line FDCPmixA4, we devised a construct for protein expression that results in the insertion of a FLAG tag sequence at the N terminus of the SPS2 protein. This strategy allowed us to document the readthrough of the in-frame TGA codon and the incorporation of 75Se into SPS2. These results suggest the existence of an autoregulatory mechanism involving the incorporation of Sec into SPS2 that might be relevant to blood cell biology. This mechanism is likely to have been present in ancient life forms and conserved in a variety of living organisms from all domains of life.


Subject(s)
Archaea/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Drosophila Proteins , Escherichia coli/metabolism , Phosphotransferases , Selenocysteine/metabolism , Amino Acid Sequence , Animals , Archaea/genetics , Bacterial Proteins/chemistry , Base Sequence , COS Cells , Chromosome Mapping , Cloning, Molecular , Escherichia coli/genetics , Female , Genetic Markers , Humans , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Phylogeny , Polymerase Chain Reaction , Selenium/metabolism , Sequence Homology, Amino Acid , Transfection
15.
J Immunol ; 155(9): 4248-54, 1995 Nov 01.
Article in English | MEDLINE | ID: mdl-7594582

ABSTRACT

The present study demonstrates that IL-4 induces germ-line IgE heavy chain (epsilon) gene transcription in human fetal splenic mononuclear cells; fetal bone marrow cells; highly purified sorted surface (s) mu+, CD10+, CD19+ immature B cells; and s mu-, cytoplasmic mu+, CD10+, CD19+ pre-B cells derived from human fetal bone marrow. Similar to observations in normal adult B cells, TGF-beta and IFN-gamma inhibited IL-4-induced germ-line epsilon RNA synthesis in fetal pre-B cells, whereas anti-CD40 mAbs and TNF-alpha had enhancing effects, suggesting that the general mechanisms regulating germ-line epsilon transcription in adult B cells and pre-B cells are similar. IL-13 also induced germ-line epsilon RNA synthesis in s mu+, CD10+, CD19+ immature B cells, but the level of transcription induced by IL-13 was significantly less than that induced by IL-4. Anti-CD40 mAbs strongly synergized with both IL-4 and IL-13 in inducing germ-line epsilon RNA synthesis by fetal immature B cells. Interestingly, IL-13 failed to induce germ-line epsilon RNA synthesis in s mu- pre-B cells even in the presence of anti-CD40 mAbs. These distinct effects of IL-4 and IL-13 suggest that functional IL-13R are expressed at a later stage of B cell ontogeny than IL-4R, and that IL-13, in contrast to IL-4, does not regulate pre-B cell differentiation. Given the fact that IL-4 production appears to be enhanced in atopic individuals, the capacity of IL-4 to induce germ-line epsilon transcription in human fetal immature B cells and pre-B cells suggests that commitment of B cell precursors to IgE-producing cells may occur during intrauterine life and may explain the increased IgE production in neonates with a family history of atopy.


Subject(s)
Antigens, CD/genetics , B-Lymphocytes/metabolism , Genes, Immunoglobulin , Immunoglobulin E/biosynthesis , Immunoglobulin Heavy Chains/genetics , Interleukin-13/genetics , Interleukin-4/genetics , Receptors, Interleukin/biosynthesis , Receptors, Interleukin/genetics , Antigens, CD/physiology , B-Lymphocytes/cytology , Base Sequence , Bone Marrow Cells , Cell Differentiation/genetics , Cell Differentiation/immunology , Fetus , Humans , Immunoglobulin E/genetics , Interleukin-13/immunology , Interleukin-13 Receptor alpha1 Subunit , Interleukin-4/immunology , Molecular Sequence Data , Receptors, Interleukin/physiology , Receptors, Interleukin-13 , Receptors, Interleukin-4 , Spleen/cytology , Transcription, Genetic/immunology
16.
J Immunol ; 155(1): 203-9, 1995 Jul 01.
Article in English | MEDLINE | ID: mdl-7602097

ABSTRACT

We describe the isolation of a cDNA that encodes human lymphotactin (Ltn), a new class of lymphocyte-specific chemokine. Human Ltn shows similarity to some members of the C-C chemokine family but has lost the first and third cysteine residues that are characteristic of the C-C and C-X-C chemokines. Ltn is chemotactic for lymphocytes but not for monocytes, a characteristic that makes it unique among chemokines. In addition, calcium flux desensitization studies indicate that Ltn uses a unique receptor. The human Ltn gene maps to a different chromosome than do the C-C and C-X-C chemokine families. Taken together, these characteristics indicate that Ltn is the first example of a new class of human chemokines with preferential effects on lymphocytes.


Subject(s)
Chemokines, C , Lymphokines/genetics , Lymphokines/physiology , Sialoglycoproteins/genetics , Sialoglycoproteins/physiology , Amino Acid Sequence , Base Sequence , Blotting, Northern , Blotting, Southern , Calcium/metabolism , Chemotaxis, Leukocyte/genetics , Chromosome Mapping/methods , Cloning, Molecular/methods , Gene Library , Humans , Lymphokines/analysis , Molecular Sequence Data , RNA, Messenger/biosynthesis , Recombinant Proteins/biosynthesis , Sialoglycoproteins/analysis , T-Lymphocyte Subsets/immunology , Thymus Gland/immunology
17.
Nature ; 376(6537): 260-3, 1995 Jul 20.
Article in English | MEDLINE | ID: mdl-7617038

ABSTRACT

Optimal T-cell activation and T-cell expansion require triggering by T-cell antigen receptors and co-stimulatory signals provided by accessory cells. A major co-stimulatory pathway involves crosslinking the CD28 molecule on T cells by its ligands CD80 or CD86 expressed on antigen-presenting cells. But recent studies on CD28-deficient mice have indicated that CD28 is not required for all T-cell responses and that additional T-cell co-stimulatory pathways exist. Here we describe a novel glycoprotein, of relative molecular mass 70,000 (M(r) 70K), designated SLAM, that belongs to the immunoglobulin gene superfamily, which is involved in T-cell stimulation. SLAM is constitutively expressed on peripheral-blood CD45ROhigh memory T cells, T-cell clones, immature thymocytes, and a proportion of B cells, and is rapidly induced on naive T cells after activation. Engagement of SLAM enhances antigen-specific proliferation and cytokine production by T cells carrying the CD4 antigen (CD4+). Particularly, the production of interferon-gamma (IFN-gamma) is strongly upregulated, even in T helper type 2 (Th2) CD4+ T-cell clones, whereas no induction of interleukin (IL)-4 or IL-5 production was observed in Th1 clones. In addition, the engagement of SLAM induces directly the proliferation of CD4+ T-cell clones and preactivated T cells, in the absence of any other stimuli, and without CD28 involvement. Thus SLAM is a novel receptor on T cells that, when engaged, potentiates T-cell expansion in a CD28-independent manner and induces a Th0/Th1 cytokine production profile.


Subject(s)
Glycoproteins/immunology , Immunoglobulins/immunology , Lymphocyte Activation , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes/immunology , Amino Acid Sequence , Animals , Antibodies, Monoclonal/immunology , Antigens, CD , Base Sequence , Cell Line , Cloning, Molecular , Cytokines/biosynthesis , DNA Primers , Escherichia coli , Humans , Interferon-gamma/biosynthesis , Leukocyte Common Antigens/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Molecular Sequence Data , Polymerase Chain Reaction , Receptors, Cell Surface , Signaling Lymphocytic Activation Molecule Family Member 1 , T-Lymphocyte Subsets/immunology
18.
Semin Immunol ; 6(5): 295-301, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7532459

ABSTRACT

The CD40 ligand (CD40L) is a member of the TNF family, and has emerged as a key molecule in the contact-mediated signal required for B cell activation and differentiation. The cloned CD40L expressed on heterologous cells, or in the form of soluble multimeric molecules, can directly activate B cells and, in conjunction with cytokines, can induce Ig isotype switching in naive B cells. Patients with hyper-IgM syndrome, which results from defective CD40L expression, generally have no circulating Ig, except for IgM, indicating that the CD40L is also important for Ig isotype switching, in vivo. CD40L does not play a role in B cell development and appears not to be required for human activation and differentiation. The presence of CD40L on cells other than T cells, the relatively broad distribution of its ligand CD40, and the ability of T cells to be co-stimulated via CD40L, indicates a broader role for CD40L-CD40 mediated intercellular communication.


Subject(s)
Antigens, CD/immunology , Antigens, Differentiation, B-Lymphocyte/immunology , B-Lymphocytes/immunology , Immunoglobulin Class Switching/immunology , Lymphocyte Activation/immunology , Membrane Glycoproteins/immunology , Antigens, CD/biosynthesis , Antigens, Differentiation, B-Lymphocyte/biosynthesis , CD40 Antigens , CD40 Ligand , Cell Communication/immunology , Humans , Lymphocyte Cooperation/immunology , Membrane Glycoproteins/biosynthesis , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL